Contact us

SeqOne S.A.S

SeqOne S.A.S.
22 Rue Durand
34000 Montpellier, France
+33 (0) 9 54 40 42 84

SeqOne raises €3m to accelerate the adoption of genetic testing in healthcare

SeqOne announces a three million euro funding round led by Elaia with IRDI / SORIDEC and supported by BPI France.  The funding will accelerate the development of SeqOne’s genetic analysis platform combining AI and big data approaches to  make genetic analysis more accessible to doctors treating cancer and hereditary diseases. [Dateline: Montpellier 28/03/2019]  Chronic conditions […]

> Read the full article here

Canadian and French startups announce genomics partnership to better diagnose rare disease

  February 28th, 2018: Paris, France & Toronto, Canada Gene42 Inc., a Toronto company that develops software for precision medicine, and SeqOne, a French life science company providing genomic data analysis solutions for healthcare, announced their partnership to accelerate rare disease diagnosis. There are roughly 7,000 rare diseases, with patients waiting on average 5–7 years […]

> Read the full article here

SeqOne wins prestigious iLab grant to improve genomics analysis software in healthcare

Montpellier 12th of July, 2017:  SeqOne a French start-up in the genomic medicine market is proud to announce that it has been awarded an i-Lab grant by the Ministry of Education and Technology.  i-Lab is a national competition open to all French start-ups designed to identify the most promising technical innovations by France’s most forward-thinking […]

> Read the full article here

Next generation genomic analysis for next generation healthcare